Zobrazeno 1 - 10
of 16
pro vyhledávání: '"G R, Kraag"'
Autor:
Peter Tugwell, David E. Yocum, C M Stein, Robert J. R. McKendry, George A. Wells, G. R. Kraag, Raye H. Brooks, John Tesser, Theodore Pincus, Torley H, Oscar Gluck
Publikováno v:
Arthritis & Rheumatism. 40:1843-1851
Objective. To determine whether the clinical benefit and favorable safety profile previously noted with the combination of cyclosporine (CSA) and methotrexate (MTX) given for 24 weeks in patients with rheumatoid arthritis (RA) would be maintained for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c31104eeee04582b9687750cd2840f2a
https://doi.org/10.1002/art.1780401018
https://doi.org/10.1002/art.1780401018
Autor:
Hyman Tannenbaum, Anthony S. Russell, S. H. K. Huang, Nicholas Bellamy, Claire Bombardier, J. Campbell, André D. Beaulieu, Ménard Ha, M. Willans, G. R. Kraag
Publikováno v:
Current Medical Research and Opinion. 12:640-651
SummaryOne hundred and twenty-three patients with osteoarthritis (n = 50) or rheumatoid arthritis (n = 73) were enrolled in a 6-week, double-blind, randomized, controlled, parallel trial comparing enteric-coated naproxen with standard naproxen. Ninet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a04c1d6561e7d1c48ba241efc248d1d
https://doi.org/10.1185/03007999209111531
https://doi.org/10.1185/03007999209111531
Publikováno v:
The Journal of rheumatology. 28(11)
High dose methotrexate (MTX) has been linked with bone loss in oncology patients. However, it is unclear whether longterm low dose MTX used in the treatment of inflammatory arthritis is associated with bone loss. We compared the effect of low dose MT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efcc295e0831b97bfd7dd19346ace05d
https://pubmed.ncbi.nlm.nih.gov/11708409
https://pubmed.ncbi.nlm.nih.gov/11708409
Autor:
I F, Anderson, T, Helve, P, Hannonen, M, Leirisalo-Repo, I M, Gilboe, M, Nissilä, E C, Keystone, G R, Kraag, O, Bjørneboe, A, Chalmers, H, Dovland, E, Mueller, F, Richard, I, Whatmough, A G, Schmidt, J M, Kovarik
Publikováno v:
The Journal of rheumatology. 26(3)
To assess whether patients with rheumatoid arthritis (RA) may be converted, on a milligram-to-milligram basis, from conventional cyclosporin A (CyA, Sandimmun) to the microemulsion formulation (Neoral) with maintenance of longterm safety, and to comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f31dad43a133c5ef1ead8c0dd2a9360
https://pubmed.ncbi.nlm.nih.gov/10090162
https://pubmed.ncbi.nlm.nih.gov/10090162
Autor:
N, Bellamy, W G, Bensen, A, Beaulieu, K A, Siminovitch, G R, Kraag, A, Lussier, S, Ahmad, V N, Khanna, P, Davis, M J, Bell
Publikováno v:
The Journal of rheumatology. 22(5)
To conduct the first Canadian study of the comparative efficacy and safety of nabumetone and diclofenac SR in patients with primary osteoarthritis (OA) of the hip, knee and shoulder.Nabumetone 1000-1500 mg po daily was compared to diclofenac SR 100-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53fc0394b34dffe844222f8199211847
https://pubmed.ncbi.nlm.nih.gov/8587082
https://pubmed.ncbi.nlm.nih.gov/8587082
Autor:
S, Barr, N, Bellamy, W W, Buchanan, A, Chalmers, P M, Ford, W F, Kean, G R, Kraag, E, Gerecz-Simon, J, Campbell
Publikováno v:
The Journal of rheumatology. 21(11)
To compare signal versus aggregate measurement strategies using the VA3.0S version of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis (OA) Index.Seventy patients with OA of the knee were asked to identify a signal item for each o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::124e8fb695aebfe4312ca10edd942269
https://pubmed.ncbi.nlm.nih.gov/7869318
https://pubmed.ncbi.nlm.nih.gov/7869318
Publikováno v:
Clinical therapeutics. 16(3)
This study evaluated factors that may influence patient compliance and also confirmed tolerability and efficacy of tenoxicam in routine clinical practice. Compliance in 1809 patients was evaluated over a 4-week period by physician pill-counts, patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57b76ccd12e7cb08c3d55c6ec05b3b43
https://pubmed.ncbi.nlm.nih.gov/7923322
https://pubmed.ncbi.nlm.nih.gov/7923322
Autor:
N, Bellamy, W W, Buchanan, A, Chalmers, P M, Ford, W F, Kean, G R, Kraag, E, Gerecz-Simon, J, Campbell
Publikováno v:
The Journal of rheumatology. 20(6)
To conduct the first Canadian study of the comparative efficacy and safety of tenoxicam and diclofenac in patients with primary osteoarthritis (OA) of the knee.Tenoxicam 20 mg per os once daily (po od) was compared to diclofenac (Voltaren) 50 mg per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0129b55ebbe582446ceae08fa605320
https://pubmed.ncbi.nlm.nih.gov/8350339
https://pubmed.ncbi.nlm.nih.gov/8350339
Publikováno v:
The Journal of rheumatology. 20(3)
To determine the point at which differences in clinical assessment scores on physical ability, pain and overall condition are sufficiently large to correspond to a subjective perception of a meaningful difference from the perspective of the patient.F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8db5accac17fd26a4caacb0c71c05771
https://pubmed.ncbi.nlm.nih.gov/8478873
https://pubmed.ncbi.nlm.nih.gov/8478873
Autor:
M. Willans, Nicholas Bellamy, G. R. Kraag, Boulos Haraoui, P. Ryan, S. Carette, N. J. Ryley, W. W. Buchanan, Denis Choquette, P. Corey, V. N. Khanna, Ménard Ha, A. Fitzgerald, Jean-Pierre Pelletier, J. S. Percy, Anthony S. Russell
Publikováno v:
Current Medical Research and Opinion. 11:16-27
SummaryA two-part multi-centre study was carried out to assess the efficacy and tolerability of a new controlled-release (CR) naproxen tablet in the treatment of osteoarthritis and rheumatoid arthritis. Patients already receiving naproxen on a regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2277c408be5473037669dd644ae3f2c
https://doi.org/10.1185/03007998809111126
https://doi.org/10.1185/03007998809111126